digital PCR
Qiagen QiAcuityDx Digital PCR System Gets Regulatory Clearance in Australia, New Zealand
The system is currently available with research-use assays, and the firm expects to launch precision cancer tests in the future.
Bio-Rad Revenue Growth 'Back to Normal' as Firm Postpones Integrated Digital PCR Launch Indefinitely
Premium
Bio-Rad confirmed its full-year guidance, reflecting a slower gradual pace of biopharma end market recovery and growth for the clinical diagnostics group.
Qiagen Targets Oncohematology, Companion Diagnostics Space With Clinical Digital PCR Instrument
Premium
The firm launched the QiAcuityDx system on Monday and will seek US Food and Drug Administration 510(k) clearance along with a BCR-ABL assay.
Qiagen Gets CE-IVDR Certification for QiaStat-Dx Instruments, Assays
The German molecular diagnostics and reagents firm said it has converted more than 80 percent of a planned total of 180 products to the new IVDR regulatory framework.
Bio-Rad Laboratories Q2 Revenues Decline 6 Percent, Firm Lowers Full-Year Outlook
Bio-Rad is expecting a decline in revenues for the full year due to a slower pace of recovery among customers of its core businesses.
Apr 19, 2023
Feb 17, 2023
Bio-Rad Q4 Revenues Flat, Miss Analyst Estimates
Jul 28, 2022
Mar 25, 2022
Mar 22, 2022
Feb 12, 2021